These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Intravitreal injection of corticosteroid attenuates leukostasis and vascular leakage in experimental diabetic retina. Tamura H; Miyamoto K; Kiryu J; Miyahara S; Katsuta H; Hirose F; Musashi K; Yoshimura N Invest Ophthalmol Vis Sci; 2005 Apr; 46(4):1440-4. PubMed ID: 15790913 [TBL] [Abstract][Full Text] [Related]
8. Integrin-mediated neutrophil adhesion and retinal leukostasis in diabetes. Barouch FC; Miyamoto K; Allport JR; Fujita K; Bursell SE; Aiello LP; Luscinskas FW; Adamis AP Invest Ophthalmol Vis Sci; 2000 Apr; 41(5):1153-8. PubMed ID: 10752954 [TBL] [Abstract][Full Text] [Related]
9. An endothelin type A receptor antagonist reverses upregulated VEGF and ICAM-1 levels in streptozotocin-induced diabetic rat retina. Masuzawa K; Goto K; Jesmin S; Maeda S; Miyauchi T; Kaji Y; Oshika T; Hori S Curr Eye Res; 2006 Jan; 31(1):79-89. PubMed ID: 16421022 [TBL] [Abstract][Full Text] [Related]
10. Leukostasis and pigment epithelium-derived factor in rat models of diabetic retinopathy. Matsuoka M; Ogata N; Minamino K; Matsumura M Mol Vis; 2007 Jun; 13():1058-65. PubMed ID: 17653050 [TBL] [Abstract][Full Text] [Related]
11. Role of alpha 4 integrin (CD49d) in the pathogenesis of diabetic retinopathy. Iliaki E; Poulaki V; Mitsiades N; Mitsiades CS; Miller JW; Gragoudas ES Invest Ophthalmol Vis Sci; 2009 Oct; 50(10):4898-904. PubMed ID: 19553613 [TBL] [Abstract][Full Text] [Related]
12. Aquaporin 4 knockdown exacerbates streptozotocin-induced diabetic retinopathy through aggravating inflammatory response. Cui B; Sun JH; Xiang FF; Liu L; Li WJ Exp Eye Res; 2012 May; 98():37-43. PubMed ID: 22449442 [TBL] [Abstract][Full Text] [Related]
13. Retinal vascular endothelial growth factor induces intercellular adhesion molecule-1 and endothelial nitric oxide synthase expression and initiates early diabetic retinal leukocyte adhesion in vivo. Joussen AM; Poulaki V; Qin W; Kirchhof B; Mitsiades N; Wiegand SJ; Rudge J; Yancopoulos GD; Adamis AP Am J Pathol; 2002 Feb; 160(2):501-9. PubMed ID: 11839570 [TBL] [Abstract][Full Text] [Related]
14. Pathogenetic potential of leukocytes in diabetic retinopathy. Miyamoto K; Ogura Y Semin Ophthalmol; 1999 Dec; 14(4):233-9. PubMed ID: 10758224 [TBL] [Abstract][Full Text] [Related]
15. Inhibition of diabetic leukostasis and blood-retinal barrier breakdown with a soluble form of a receptor for advanced glycation end products. Kaji Y; Usui T; Ishida S; Yamashiro K; Moore TC; Moore J; Yamamoto Y; Yamamoto H; Adamis AP Invest Ophthalmol Vis Sci; 2007 Feb; 48(2):858-65. PubMed ID: 17251488 [TBL] [Abstract][Full Text] [Related]
17. Inducible nitric oxide synthase isoform is a key mediator of leukostasis and blood-retinal barrier breakdown in diabetic retinopathy. Leal EC; Manivannan A; Hosoya K; Terasaki T; Cunha-Vaz J; Ambrósio AF; Forrester JV Invest Ophthalmol Vis Sci; 2007 Nov; 48(11):5257-65. PubMed ID: 17962481 [TBL] [Abstract][Full Text] [Related]
18. Aldose reductase inhibitor fidarestat attenuates leukocyte-endothelial interactions in experimental diabetic rat retina in vivo. Hattori T; Matsubara A; Taniguchi K; Ogura Y Curr Eye Res; 2010 Feb; 35(2):146-54. PubMed ID: 20136425 [TBL] [Abstract][Full Text] [Related]
19. Pigment epithelium-derived factor (PEDF) prevents diabetes- or advanced glycation end products (AGE)-elicited retinal leukostasis. Yamagishi S; Matsui T; Nakamura K; Takeuchi M; Imaizumi T Microvasc Res; 2006; 72(1-2):86-90. PubMed ID: 16797605 [TBL] [Abstract][Full Text] [Related]
20. Role of angiotensin II in retinal leukostasis in the diabetic rat. Chen P; Scicli GM; Guo M; Fenstermacher JD; Dahl D; Edwards PA; Scicli AG Exp Eye Res; 2006 Nov; 83(5):1041-51. PubMed ID: 16822509 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]